Avadel Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AVDL and other ETFs, options, and stocks.About AVDL
Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its main product is LUMRYZ is an extended-release formulation of sodium oxybate, which used in the treatment of cataplexy or EDS in adults with narcolepsy.
CEOGregory J. Divis
CEOGregory J. Divis
Employees188
Employees188
HeadquartersDublin, Dublin
HeadquartersDublin, Dublin
Founded2015
Founded2015
Employees188
Employees188
AVDL Key Statistics
Market cap1.84B
Market cap1.84B
Price-Earnings ratio-3,447.27
Price-Earnings ratio-3,447.27
Dividend yield—
Dividend yield—
Average volume3.70M
Average volume3.70M
High today$18.98
High today$18.98
Low today$18.83
Low today$18.83
Open price$18.94
Open price$18.94
Volume813.66K
Volume813.66K
52 Week high$19.06
52 Week high$19.06
52 Week low$6.38
52 Week low$6.38
Stock Snapshot
The current Avadel Pharmaceuticals(AVDL) stock price is $18.88, with a market capitalization of 1.84B. The stock trades at a price-to-earnings (P/E) ratio of -3447.27.
On 2025-11-06, Avadel Pharmaceuticals(AVDL) stock traded between a low of $18.83 and a high of $18.98. Shares are currently priced at $18.88, which is +0.3% above the low and -0.5% below the high.
Avadel Pharmaceuticals(AVDL) shares are trading with a volume of 813.66K, against a daily average of 3.7M.
During the past year, Avadel Pharmaceuticals(AVDL) stock moved between $6.38 at its lowest and $19.06 at its peak.
During the past year, Avadel Pharmaceuticals(AVDL) stock moved between $6.38 at its lowest and $19.06 at its peak.
Analyst ratings
100%
of 10 ratingsBuy
0%
Hold
100%
Sell
0%
People also own
Based on the portfolios of people who own AVDL. This list is generated using Robinhood data, and it’s not a recommendation.